drugset / Trial / NCT05449132

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

NCT05449132 ↗

Phase 3 Completed 466 enrolled Grünenthal GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of single injection of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.

Timeline

Start
2022-09-26
Primary completion
2024-08-15
Completion
2024-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject RTX-GRT7039 Unknown — Other

Indications